Verapamil Hydrochloride
NDC 54868-2207
Product Information
Verapamil Hydrochloride is a ANDA-approved product labeled by Physicians Total Care, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a blue product. This product entry covers the primary NDC 54868-2207 and 6 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
15 MM
19 MM
MYLAN;244
M;312
M;411
2
Code Structure Chart
Product Details
What is NDC 54868-2207?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- VERAPAMIL HYDROCHLORIDE (UNII: V3888OEY5R)
- VERAPAMIL (UNII: CJ0O37KU29) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)
- POLYVINYL ALCOHOL (UNII: 532B59J990)
- POVIDONE (UNII: FZ989GH94E)
- SODIUM ALGINATE (UNII: C269C4G2ZQ)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 897640 - verapamil HCl 180 MG Extended Release Oral Tablet
- RxCUI: 897640 - verapamil hydrochloride 180 MG Extended Release Oral Tablet
- RxCUI: 897649 - verapamil HCl 240 MG Extended Release Oral Tablet
- RxCUI: 897649 - verapamil hydrochloride 240 MG Extended Release Oral Tablet
- RxCUI: 897659 - verapamil HCl 120 MG Extended Release Oral Tablet
* Please review the full disclaimer at the bottom of this page.